RPCEC00000117招募中4 期
Evaluation of molecular response to treatment with Heberprot-P in patients with diabetic foot ulcers”.
Center for Genetic Engineering and Biotechnology (CIGB).0 个研究点目标入组 156 人开始时间: 2011年5月20日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 156
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study. Masking: Open. Control Group: Uncontrolled. Assignment: Single Group. Purpose: Treatment
入排标准
- 年龄范围
- 18 years 至 /A (No limit)(—)
- 性别
- All
入选标准
- •1) Have given informed consent. 2) Patients with diabetes mellitus type 1 or 2 according to the criteria of the American Diabetes Association. 3) Age = 18 years. 4) Diabetic foot ulcer deep, complicated, and no clinical signs of infection. 5) Diabetic foot ulcer with an area = 2 cm2. 6) Patients with ischemic ulcers with pressures between 0.8 to 0.3 index.
排除标准
- •1) Signs or symptoms of local infection. 2) Complete granulating ulcer. 3) Pretreatment with epidermal growth factor (EGF) topically or by any means in order to study injury or other injury in the 4 weeks prior to treatment with EGF. 4) Connective tissue diseases. 5) Decompensated or severe systemic diseases: heart disease (acute myocardial infarction in the previous three months, unstable angina or heart failure with edema), moderate or severe hepatic insufficiency, renal insufficiency with serum creatinine > 200 umol/L. 6) Current or history of malignancy in the past. 7) Psychiatric or neurological diseases that prevent the patient to give consent to participate in the study. 8) Hemoglobin < 100 g/L. 9) Clinical signs of malnutrition or albumin < 30 g/L. 10) Hypersensitivity to the product or any of its components. 11) Pregnancy and lactation.
研究者
相似试验
招募中
2 期
Prospective Evaluation of the Molecular Effects of Itraconazoleas an anti-cancer agent: A Window of Opportunity Studysolid tumorsJPRN-UMIN000018388Hyogo College of Medicine20
招募中
2 期
Window trialJPRN-jRCTs051190006Tsubamoto Hiroshi200
尚未招募
2 期
A clinical trial to study the effects photodynamic therapy in patients with gum diseases.CTRI/2024/06/068905Shweta S Patil
招募中
2 期
Study of changes in cancer tissue induced by treatment with bevacizumab in metastatic breast cancermetastatic breast cancerCancer - BreastACTRN12609000904279Georgios Kesisis40
尚未招募
2 期
Discover the Power of Homoeopathic Calcarea Fluor 6x for Knee HealthCTRI/2024/07/071629Jawaharlal Nehru Homoeopathic Medical And Hospital
